BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 12, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ConXn: Phase II data; Phase II/III

CNCT published in the Annals of Internal Medicine data from a 68-patient U.S. Phase II trial showing a statistically significant improvement in Modified Rodnan Skin Score at 4, 12 and 24 weeks in patients given a 25...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >